Dalia Haydar, Pharm.D., Ph.D.
- Research Faculty
- Principal Investigator, Program for Cell Enhancement and Technologies for Immunotherapies (CETI)
Dalia Haydar, Pharm.D., Ph.D., is an assistant professor of Pediatrics at the George Washington University School of Medicine and Health Sciences. She is also a research faculty at the Center for Cancer and Immunology Research at Children's National Hospital, where she leads efforts for developing CAR T cell immunotherapy for pediatric brain tumors. Dr. Haydar's primary interest is understanding host factors that limit responses to adoptive immunotherapies. Using mechanistic investigations and cutting-edge technologies, Dr. Haydar is trying to develop next-generation cellular immunotherapies that would advance outcomes in pediatric patients with brain tumors.